DAIHAN Scientific Co. Ltd (131220) - Net Assets
Based on the latest financial reports, DAIHAN Scientific Co. Ltd (131220) has net assets worth ₩56.60 Billion KRW (≈ $38.36 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩70.44 Billion ≈ $47.74 Million USD) and total liabilities (₩13.84 Billion ≈ $9.38 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of DAIHAN Scientific Co. Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩56.60 Billion |
| % of Total Assets | 80.35% |
| Annual Growth Rate | 7.46% |
| 5-Year Change | 44.5% |
| 10-Year Change | 83.01% |
| Growth Volatility | 4.82 |
DAIHAN Scientific Co. Ltd - Net Assets Trend (2012–2024)
This chart illustrates how DAIHAN Scientific Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore DAIHAN Scientific Co. Ltd total assets for the complete picture of this company's asset base.
Annual Net Assets for DAIHAN Scientific Co. Ltd (2012–2024)
The table below shows the annual net assets of DAIHAN Scientific Co. Ltd from 2012 to 2024. For live valuation and market cap data, see market cap of DAIHAN Scientific Co. Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩42.22 Billion ≈ $28.61 Million |
+7.72% |
| 2023-12-31 | ₩39.20 Billion ≈ $26.56 Million |
+7.59% |
| 2022-12-31 | ₩36.43 Billion ≈ $24.69 Million |
+11.67% |
| 2021-12-31 | ₩32.63 Billion ≈ $22.11 Million |
+11.65% |
| 2020-12-31 | ₩29.22 Billion ≈ $19.80 Million |
+3.47% |
| 2019-12-31 | ₩28.24 Billion ≈ $19.14 Million |
+10.12% |
| 2018-12-31 | ₩25.65 Billion ≈ $17.38 Million |
+6.84% |
| 2017-12-31 | ₩24.00 Billion ≈ $16.27 Million |
+2.99% |
| 2016-12-31 | ₩23.31 Billion ≈ $15.80 Million |
+1.02% |
| 2015-12-31 | ₩23.07 Billion ≈ $15.64 Million |
+4.21% |
| 2014-12-31 | ₩22.14 Billion ≈ $15.00 Million |
+19.22% |
| 2013-12-31 | ₩18.57 Billion ≈ $12.58 Million |
+4.26% |
| 2012-12-31 | ₩17.81 Billion ≈ $12.07 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to DAIHAN Scientific Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2868942143000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩28.69 Billion | 67.95% |
| Common Stock | ₩3.73 Billion | 8.83% |
| Other Components | ₩9.81 Billion | 23.23% |
| Total Equity | ₩42.22 Billion | 100.00% |
DAIHAN Scientific Co. Ltd Competitors by Market Cap
The table below lists competitors of DAIHAN Scientific Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
2B INTELLIGENT SOFT S.A.
RO:BENTO
|
$23.98 Million |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
$23.98 Million |
|
CEO Event Medya AS
IS:CEOEM
|
$23.99 Million |
|
Korea SE Corp
KQ:101670
|
$24.00 Million |
|
TherapeuticsMD Inc
NASDAQ:TXMD
|
$23.96 Million |
|
Silvair Inc
WAR:SVRS
|
$23.95 Million |
|
JPMorgan American Investment Trust
LSE:JAM
|
$23.95 Million |
|
Ropharma Bras
RO:RPH
|
$23.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DAIHAN Scientific Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 39,197,071,940 to 42,222,995,860, a change of 3,025,923,920 (7.7%).
- Net income of 2,692,590,760 contributed positively to equity growth.
- Dividend payments of 697,351,110 reduced retained earnings.
- Share repurchases of 999,996,070 reduced equity.
- Other factors increased equity by 2,030,680,340.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩2.69 Billion | +6.38% |
| Dividends Paid | ₩697.35 Million | -1.65% |
| Share Repurchases | ₩1000.00 Million | -2.37% |
| Other Changes | ₩2.03 Billion | +4.81% |
| Total Change | ₩- | 7.72% |
Book Value vs Market Value Analysis
This analysis compares DAIHAN Scientific Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.77x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.46x to 0.77x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩3257.93 | ₩4745.00 | x |
| 2017-12-31 | ₩3355.36 | ₩4745.00 | x |
| 2018-12-31 | ₩3441.37 | ₩4745.00 | x |
| 2019-12-31 | ₩3789.52 | ₩4745.00 | x |
| 2020-12-31 | ₩3920.90 | ₩4745.00 | x |
| 2021-12-31 | ₩4377.83 | ₩4745.00 | x |
| 2022-12-31 | ₩4888.61 | ₩4745.00 | x |
| 2023-12-31 | ₩5559.18 | ₩4745.00 | x |
| 2024-12-31 | ₩6155.25 | ₩4745.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DAIHAN Scientific Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.38%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.76%
- • Asset Turnover: 1.06x
- • Equity Multiplier: 1.61x
- Recent ROE (6.38%) is above the historical average (5.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 7.10% | 3.19% | 1.21x | 1.85x | ₩-510.36 Million |
| 2013 | 3.78% | 1.75% | 1.05x | 2.06x | ₩-1.14 Billion |
| 2014 | 3.72% | 2.02% | 0.96x | 1.93x | ₩-1.33 Billion |
| 2015 | -7.01% | -3.65% | 1.02x | 1.87x | ₩-3.68 Billion |
| 2016 | 7.82% | 3.96% | 1.13x | 1.75x | ₩-506.99 Million |
| 2017 | 4.24% | 2.46% | 1.12x | 1.54x | ₩-1.38 Billion |
| 2018 | 6.96% | 3.79% | 1.21x | 1.52x | ₩-779.21 Million |
| 2019 | 4.34% | 2.22% | 1.24x | 1.57x | ₩-1.60 Billion |
| 2020 | 5.85% | 2.78% | 1.37x | 1.54x | ₩-1.21 Billion |
| 2021 | 11.55% | 5.68% | 1.21x | 1.68x | ₩504.84 Million |
| 2022 | 12.91% | 6.51% | 1.22x | 1.63x | ₩1.06 Billion |
| 2023 | 9.81% | 5.22% | 1.15x | 1.63x | ₩-74.40 Million |
| 2024 | 6.38% | 3.76% | 1.06x | 1.61x | ₩-1.53 Billion |
Industry Comparison
This section compares DAIHAN Scientific Co. Ltd's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $97,872,631,928
- Average return on equity (ROE) among peers: 7.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DAIHAN Scientific Co. Ltd (131220) | ₩56.60 Billion | 7.10% | 0.24x | $23.96 Million |
| NanoenTekInc (039860) | $45.49 Billion | 6.02% | 0.16x | $149.06 Million |
| THINKWARE Corporation (084730) | $163.77 Billion | 3.98% | 0.74x | $62.37 Million |
| Suprema HQ Inc (094840) | $174.01 Billion | 7.22% | 0.18x | $70.37 Million |
| Woojin (105840) | $131.03 Billion | -5.57% | 0.61x | $374.32 Million |
| HyVision System. Inc (126700) | $123.98 Billion | 6.77% | 0.34x | $155.89 Million |
| Parksystems Corp (140860) | $90.14 Billion | 10.08% | 0.49x | $1.36 Billion |
| LET co. Ltd (297890) | $30.28 Billion | 24.36% | 0.77x | $114.00 Million |
| Wintec Co. Ltd (320000) | $24.28 Billion | 6.43% | 0.60x | $33.57 Million |
About DAIHAN Scientific Co. Ltd
DAIHAN Scientific Co., Ltd. manufactures and supplies laboratory instruments and medical devices in South Korea and internationally. It offers autoclaves, balances, centrifuges, evaporators, gel documentation systems, heating stirrers, mills, shakers, viscometers, refrigerators/freezers, bath circulators, chillers/cooling circulators, freeze dry systems, glass/labware washers, heating mantles, ho… Read more